In VIVO CAR-T Therapy for Relapsed/Refractory Hematological Malignancies | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
In VIVO CAR-T Therapy for Relapsed/Refractory Hematological Malignancies	B-cell neoplasm, Blood Protein Disorders, Burkitt lymphoma, DNA Virus Infections, Epstein-Barr virus infection, Hemic and Lymphatic Diseases, Herpesviridae infectious disease, Infections, Neoplasms by Histologic Type, Tumor Virus Infections, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease, viral infectious disease	Recruiting	Phase 1	2025-11-20		NCT07239323

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Chongqing Precision Biotech Co., Ltd	34

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China	Kunming	China	2